Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02655822
Title Phase 1/1b Study to Evaluate the Safety and Tolerability of Ciforadenant Alone and in Combination With Atezolizumab in Advanced Cancers
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Corvus Pharmaceuticals, Inc.
Indications

renal cell carcinoma

prostate adenocarcinoma

Therapies

Atezolizumab + CPI-444

CPI-444

Age Groups: senior | adult
Covered Countries USA | CAN

Facility Status City State Zip Country Details
University of Arizona Cancer Center Recruiting Tucson Arizona 85719 United States Details
University of California - San Francisco Recruiting San Francisco California 94143 United States Details
Stanford Cancer Institute Completed Stanford California 94305 United States Details
Yale University Recruiting New Haven Connecticut 06510 United States Details
University of Miami Hospital and Clinics Completed Miami Florida 33136 United States Details
Rush University Medical Center Completed Chicago Illinois 60612 United States Details
University of Chicago Medical Center Completed Chicago Illinois 60637 United States Details
Sidney Kimmel Comprehensive Cancer Center - Johns Hopkins University School of Medicine Completed Baltimore Maryland 21287 United States Details
Massachusetts General Hospital Completed Boston Massachusetts 02114 United States Details
Karmanos Cancer Institute Completed Detroit Michigan 48201 United States Details
Roswell Park Cancer Institute Recruiting Buffalo New York 14263 United States Details
Memorial Sloan Kettering Cancer Center Completed New York New York 10065 United States Details
Cleveland Clinic Completed Cleveland Ohio 44195 United States Details
University of Pittsburgh Medical Center Cancer Center Recruiting Pittsburgh Pennsylvania 15232 United States Details
Medical College of Wisconsin Completed Milwaukee Wisconsin 53226 United States Details
Royal Brisbane and Women's Hospital Completed Brisbane Queensland 4029 Australia Details
Monash Health Completed Clayton Victoria 3168 Australia Details
Cross Cancer Institute Completed Edmonton Alberta T6G 1Z2 Canada Details
British Columbia Cancer Agency - Vancouver Centre Completed Vancouver British Columbia V5Z 4E6 Canada Details
The Ottawa Hospital Cancer Centre Recruiting Ottawa Ontario K1H 8L6 Canada Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field